Nicox Sa Stock Current Liabilities
| NICXFDelisted Stock | USD 0.44 0.00 0.00% |
Nicox SA fundamentals help investors to digest information that contributes to Nicox SA's financial success or failures. It also enables traders to predict the movement of Nicox Pink Sheet. The fundamental analysis module provides a way to measure Nicox SA's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Nicox SA pink sheet.
Nicox |
Nicox SA Company Current Liabilities Analysis
Nicox SA's Current Liabilities is the company's short term debt. This usually includes obligations that are due within the next 12 months or within one fiscal year. Current liabilities are very important in analyzing a company's financial health as it requires the company to convert some of its current assets into cash.
Current Nicox SA Current Liabilities | 31 M |
Most of Nicox SA's fundamental indicators, such as Current Liabilities, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Nicox SA is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Current liabilities appear on the company's balance sheet and include all short term debt accounts, accounts and notes payable, accrued liabilities as well as current payments due on the long-term loans. One of the most useful applications of Current Liabilities is the current ratio which is defined as current assets divided by its current liabilities. High current ratios mean that current assets are more than sufficient to pay off current liabilities.
CompetitionIn accordance with the recently published financial statements, Nicox SA has a Current Liabilities of 31 M. This is 98.23% lower than that of the Healthcare sector and 94.29% lower than that of the Biotechnology industry. The current liabilities for all United States stocks is 99.61% higher than that of the company.
Nicox Current Liabilities Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Nicox SA's direct or indirect competition against its Current Liabilities to detect undervalued stocks with similar characteristics or determine the pink sheets which would be a good addition to a portfolio. Peer analysis of Nicox SA could also be used in its relative valuation, which is a method of valuing Nicox SA by comparing valuation metrics of similar companies.Nicox SA is currently under evaluation in current liabilities category among its peers.
Nicox Fundamentals
| Return On Equity | -0.65 | |||
| Return On Asset | -0.0905 | |||
| Operating Margin | (2.29) % | |||
| Current Valuation | 54.64 M | |||
| Shares Outstanding | 50.16 M | |||
| Shares Owned By Insiders | 6.32 % | |||
| Shares Owned By Institutions | 17.02 % | |||
| Price To Earning | 146.39 X | |||
| Price To Book | 0.99 X | |||
| Price To Sales | 5.91 X | |||
| Revenue | 8.58 M | |||
| Gross Profit | 7.23 M | |||
| EBITDA | (15.96 M) | |||
| Net Income | (43.76 M) | |||
| Cash And Equivalents | 41.97 M | |||
| Cash Per Share | 0.98 X | |||
| Total Debt | 20.52 M | |||
| Debt To Equity | 0.28 % | |||
| Current Ratio | 5.97 X | |||
| Book Value Per Share | 1.41 X | |||
| Cash Flow From Operations | (18.48 M) | |||
| Earnings Per Share | (1.23) X | |||
| Number Of Employees | 32 | |||
| Beta | 0.96 | |||
| Market Capitalization | 47.99 M | |||
| Total Asset | 114.61 M | |||
| Retained Earnings | (24 M) | |||
| Working Capital | 8 M | |||
| Current Asset | 39 M | |||
| Current Liabilities | 31 M | |||
| Z Score | 1.2 | |||
| Net Asset | 114.61 M |
About Nicox SA Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Nicox SA's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Nicox SA using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Nicox SA based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Currently Active Assets on Macroaxis
Check out Correlation Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in interest. You can also try the Alpha Finder module to use alpha and beta coefficients to find investment opportunities after accounting for the risk.
Other Consideration for investing in Nicox Pink Sheet
If you are still planning to invest in Nicox SA check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Nicox SA's history and understand the potential risks before investing.
| Technical Analysis Check basic technical indicators and analysis based on most latest market data | |
| Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges | |
| Financial Widgets Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets | |
| Performance Analysis Check effects of mean-variance optimization against your current asset allocation |